Technology transfer is the process of transferring scientific findings from one organization to another for the purpose of furthering development and commercialization. Strong technology transfer policies, combined with robust patent protection, enable biotechnology companies to engage in partnering and ultimately secure the enormous financial resources needed to translate basic scientific discoveries into real-world solutions for disease, pollution, and hunger.
Thanks to the enduring effectiveness of the Bayh-Dole Act, American research universities, along with industry partners, are turning federally-funded basic research into new and valuable products that save and improve lives. The commercialization of university-based research to create new companies and good, high-paying jobs is a key driver of America’s innovation economy
Sign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.